Drug Delivery Devices Market Size & Share, by Device Type (Smart Pills, Inhalers, Drug Eluting Stents, Safety Syringes, Implantable Drug Delivery Device, Transdermal Patches); Route of Administration (Oral, Transdermal, Injectable); Distribution Channel (Hospital, Pharmacies, Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3868
  • Published Date: Aug 04, 2023
  • Report Format: PDF, PPT

Companies Dominating the Drug Delivery Devices Landscape

top-features-companies
    • Antares Pharma, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Novartis International AG
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Otsuka Pharmaceutical Co., Ltd.,
    • Abbott Laboratories
    • Cipla Limited

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Janssen Pharmaceutical Inc., a subsidiary company of Johnson & Johnson announced the FDA approval of drug Darzalex Faspro for the treatment of Multiple Myeloma Cancer.
  • IDEAYA Biosciences, Inc. and GlaxoSmithKline plc. announced a strategic partnership to develop solutions in the field of Oncology.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3868
  • Published Date: Aug 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing need for targeted drug delivery to treat cancer is estimated to boost the market growth.

The market is anticipated to attain a CAGR of ~5.5% over the forecast period, i.e., 2023 – 2035.

The North American region is anticipated to provide more business opportunities over the forecast period owing to the advancement in technology in the healthcare sector.

The major players in the market are Mylan N.V., Novartis International AG, Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Cipla Limited, and others.

The injectable segment is anticipated to hold largest market size over the forecast period and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying